Phase 1, Open-Label, Mulit-Center Study to Evaluate the Safety and Tolerability of CT-322 Administered in Combination with Focal Brain Radiotherapy and Temozolomide to Subjects with Newly Diagnosed Glioblastoma Multiforme

  • Young, Alfred (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/08 → 11/30/11